3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
8
Terminated
4
Recruiting
2
Withdrawn
1
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
9
Head and Neck Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
4
Ovarian Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Colorectal Neoplasms
3
Anus Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Carcinoma
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Select Advanced Solid Tumors
1
SCLC, Extensive Stage
1
SCLC
1
Retinoblastoma
1
Retinal Neoplasms
1
Recurrence
1
Radiation Therapy
1
Prostatic Neoplasms
1
Interventions
enzalutamide
33
Abiraterone Acetate
29
apalutamide
26
Prednisone
26
Radiotherapy
25
Magnetic Resonance Spectroscopy
25
Androgen Antagonists
24
Leuprolide
22
Radiosurgery
19
darolutamide
18
Docetaxel
17
Gonadotropin-Releasing Hormone
16
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
15
Goserelin
13
gallium 68 PSMA-11
12
bicalutamide
12
Specimen Handling
12
Radiotherapy, Intensity-Modulated
12
abiraterone
11
Radiation
11
pembrolizumab
10
Pluvicto
10
Carboplatin
9
Brachytherapy
9
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
9
relugolix
8
luprolide acetate gel depot
8
Triptorelin Pamoate
8
Standard of Care
8
Nivolumab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Prostatic Neoplasms
×
Drug Therapy
×
Clear all
NCT02454543
2026-01-12
g-RAMPP
Martini-Klinik am UKE GmbH
Phase NA
Active not recruiting
452 enrolled